Search

everythinglearnresearchcommunity

for

Search:↓

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

LLLT is a safe, promising hair loss treatment, but more research needed.

Gender identity can be more diverse than just male or female.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Non-drug therapies show promise for hair regrowth but need more research.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Mesotherapy with stem cells showed promising hair growth results in some patients with hair loss, but more research is needed.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

Both mesotherapy treatments reduced under-chin fat equally and were safe with mild side effects.

A patient experienced permanent hair loss due to an allergic reaction to a corticosteroid injection.

Neonatal mesenchymal stem cell therapy shows promise for treating hair loss but needs more research.

Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

A vibrating anesthetic device significantly reduces pain during mesotherapy for hair loss without complications.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Proteins from stem cells improved hair growth in patients with hair loss.

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

For sensitive scalp, treatment is personalized and may include specific medications and hydration, while avoiding stress and irritating products.